The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products that should not be used, sold or distributed.

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Discover why VKTX's deep selloff offers a compelling opportunity with improved safety margins, promising GLP-1 candidates, ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

SYNT-101 offers a novel approach to weight loss by temporarily altering nutrient absorption in the small intestine. Unlike ...

Current developments in the health sector include Novo Nordisk's warning about counterfeit Ozempic in the US, Sandoz's antitrust lawsuit against Amgen, and rising concerns in the biotech industry due ...

The US Food and Drug Administration (FDA) on Monday urged patients and healthcare providers to verify the authenticity of ...

Ozempic, a medication to help manage diabetes, has shot up in popularity in the US. So much so, that the US Food and Drug Administration (FDA) has issued a warning against using counterfeit Ozempic, ...

Lilly shares are up 14.2% in response to the news, while shares of its rivals in the GLP-1 weight loss market, Novo Nordisk ( ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

We came across a bullish thesis on Novo Nordisk A/S (NVO) on Substack by Felix. In this article, we will summarize the bulls’ ...